检索结果 - Mathias Schmidt

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    True

    True 由 Bolin Liu, Min Fang, Mathias Schmidt, Yang Lü, John Mendelsohn, Fan Zhang

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma

    Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma 由 Wilko Weichert, Carsten Denkert, Mathias Schmidt, Volker Gekeler, G. Wolf, Martin Köbel, Manfred Dietel, S. Hauptmann

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit thein vitro growth of human head and neck cancer cells and cause rapid tumor regressionin vivo

    Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit thein vitro growth of human head and neck cancer cells and cause rapid tumor regressionin vivo 由 Marc Azémar, Mathias Schmidt, Friederike Arlt, Pierre Kennel, Burkhard Brandt, Apollon Papadimitriou, Bernd Groner, Winfried S. Wels

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil

    Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil 由 Roberto Giugliani, Ana Maria Martins, Sairei So, Tatsuyoshi Yamamoto, Mariko Yamaoka, Toshiaki Ikeda, Kazunori Tanizawa, Hiroyuki Sonoda, Mathias Schmidt, Yuji Sato

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy

    The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy 由 Marcel Leist, Susanne Bremer, Patrik Brundin, Juergen Hescheler, Agnete Kirkeby, Karl‐Heinz Krause, Peter Poerzgen, Michel Pucéat, Mathias Schmidt, André Schrattenholz, Naomi B. Zak, Hannes Hentze

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial

    Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-id... 由 Roberto Giugliani, Luciana Giugliani, Fabiano de Oliveira Poswar, Karina Carvalho Donis, Amauri Dalla Corte, Mathias Schmidt, Rubén J. Boado, Igor Nestrašil, Carol Nguyen, Steven Chen, William M. Pardridge

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status

    Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status 由 Mathias Schmidt, Jenny Rinke, Vivien Schäfer, Susanne Schnittger, Alexander Kohlmann, Ellen Obstfelder, C. Kunert, Janine M. Ziermann, Nils Winkelmann, Ekkehard Eigendorff, Torsten Haferlach, Claudia Haferlach, Andreas Hochhaus, Thomas Ernst

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: an Integrated Analysis of Preclinical and Clinical Data

    Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: an Integrated Analysis of Preclinical and Clinical Data 由 Roberto Giugliani, Ana Maria Martins, Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Kimitoshi Nakamura, Hideto Morimoto, Kohtaro Minami, Tatsuyoshi Yamamoto, Mariko Yamaoka, Toshiaki Ikeda, Sairei So, Kazunori Tanizawa, Hiroyuki Sonoda, Mathias Schmidt, Yuji Sato

    出版 2021
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  9. 9
    Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data

    Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data 由 Roberto Giugliani, Ana Maria Martins, Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Kimitoshi Nakamura, Hideto Morimoto, Kohtaro Minami, Tatsuyoshi Yamamoto, Mariko Yamaoka, Toshiaki Ikeda, Sairei So, Kazunori Tanizawa, Hiroyuki Sonoda, Mathias Schmidt, Yuji Sato

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial

    α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial 由 Paul Harmatz, Roberto Giugliani, Ana Maria Martins, Takashi Hamazaki, Toru Kubo, Ryutaro Kira, Kohtaro Minami, Toshiaki Ikeda, Hiroaki Moriuchi, Satoshi Kawashima, Naoko Takasao, Sairei So, Hiroyuki Sonoda, Tohru Hirato, Kazunori Tanizawa, Mathias Schmidt, Yuji Sato

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: